Cardiology
A 53-year-old woman had undergone an aortic valve replacement with a Starr-Edwards valve 28 years prior, leading to cardiac failure, mitral stenosis, and mitral regurgitation. Subsequent reoperation replaced both mitral and aortic valves with St. Jude bileaflet mechanical prostheses, revealing a normally functioning Starr-Edwards prosthesis despite lipid infiltration. The replacement
Medical equipment industry
Toshiba America Medical Systems, Inc., (TAMS) and ViTAL Images, Inc. have joined forces with top cardiologists at the Johns Hopkins University School of Medicine to develop cutting-edge applications for high-resolution, multislice coronary computed tomography angiography (CTA) imaging. This collaboration aims to improve the effectiveness of noninvasive cardiovascular imaging for early
Medical equipment industry
Leading diagnostic imaging companies, Toshiba America Medical Systems, Inc. (TAMS), and ViTAL Images, Inc., have teamed up with top cardiologists at the Johns Hopkins University School of Medicine to develop advanced noninvasive cardiovascular imaging techniques for early detection of heart disease, the number one killer of Americans. This collaboration aims
Medical equipment industry
Medtronic, Inc. has announced the U.S. commercial release of two electrophysiology catheters, the Medtronic EnCirclr AL Adjustable Loop Mapping Catheter and the Medtronic RF Enhancr II Single-Curve Ablation Catheter, which have received U.S. Food and Drug Administration clearance. These new technologies aim to complement the skills of electrophysiologists
Medical equipment industry
CardioTech International, a global leader in medical devices, has announced that its subsidiary Gish Biomedical has received FDA clearance to market the Vision Blood Cardioplegia (VBC) System with Gish's proprietary GBS (Gish Biocompatible Surface) coating. The VBC System is designed for use in heart-lung bypass surgery and is
Medical equipment industry
Neoprobe Corp., a developer of oncology and cardiovascular surgical and diagnostic products, is set to meet with the U.S. Food and Drug Administration (FDA) on April 15, 2004, to discuss the submission of additional clinical information for RIGScan CR49. The meeting aims to review procedures for completing further analysis
Medical equipment industry
QMed, Inc. has signed a multi-year contract with Western Health Advantage (WHA) to provide diabetes and coronary artery disease management programs to patients and physicians of WHA. This contract marks an important milestone for QMed, expanding its commercial health plan book of business and accelerating the number of lives under
Cardiology
Research from the United States reveals that genetic factors play a significant role in determining susceptibility to atherosclerosis and influence the effects of estrogens and progestins in arterial vessel disease. A study published in the American Journal of Physiology - Endocrinology and Metabolism found that estrogen receptor (ER) and progesterone
Cardiology
Researchers at the Department of Veterans Affairs Medical Center in Minneapolis conducted a retrospective cohort study to evaluate the effectiveness of lipid-lowering medication (LLM) on all-cause mortality in patients with known coronary heart disease. The study, published in the American Journal of Cardiology, analyzed data from 16,470 patients with
